Repetitive enhancement of serum BDNF subsequent to continuation ECT

por Vanicek, T., Kranz, G. S., Vyssoki, B., Komorowski, A., Fugger, G., Höflich, A., Micskei, Z., Milovic, S., Lanzenberger, R., Eckert, A., Kasper, S., Frey, R.
Publicado 2019

Machine learning classification of ADHD and HC by multimodal serotonergic data

por Kautzky, A., Vanicek, T., Philippe, C., Kranz, G. S., Wadsak, W., Mitterhauser, M., Hartmann, A., Hahn, A., Hacker, M., Rujescu, D., Kasper, S., Lanzenberger, R.
Publicado 2020

The influence of the rs6295 gene polymorphism on serotonin-1A receptor distribution investigated with PET in patients with major depression applying machine learning

por Kautzky, A, James, G M, Philippe, C, Baldinger-Melich, P, Kraus, C, Kranz, G S, Vanicek, T, Gryglewski, G, Wadsak, W, Mitterhauser, M, Rujescu, D, Kasper, S, Lanzenberger, R
Publicado 2017

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study

por Kautzky, A., Dold, M., Bartova, L., Spies, M., Kranz, G. S., Souery, D., Montgomery, S., Mendlewicz, J., Zohar, J., Fabbri, C., Serretti, A., Lanzenberger, R., Dikeos, D., Rujescu, D., Kasper, S.
Publicado 2018

Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity–impulsivity symptoms in ADHD measured with PET

por Sigurdardottir, H. L., Kranz, G. S., Rami-Mark, C., James, G. M., Vanicek, T., Gryglewski, G., Berroterán-Infante, N., Kautzky, A., Hienert, M., Traub-Weidinger, T., Mitterhauser, M., Wadsak, W., Hartmann, A. M., Hacker, M., Rujescu, D., Kasper, S., Lanzenberger, R.
Publicado 2019